Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
Elisabeth M. Wang, PharmD, BCCP
Advertisement
Articles by Elisabeth M. Wang, PharmD, BCCP
Advertisement
Latest Updated Articles
Finerenone and the Future of Diabetes-Related Kidney CarePublished: July 15th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Controversial 340B Rebate Pilot Program Is Moving Forward
2
Striking the Balance: Evidence-Based versus Defensive Medicine
3
Researchers Identify Key Lipid Pathways That Influence Alzheimer’s Progression
4
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
5
